Wolters Kluwer (WTKWY)
(Delayed Data from OTC)
$150.50 USD
+1.01 (0.68%)
Updated Apr 22, 2024 11:18 AM ET
2-Buy of 5 2
D Value A Growth C Momentum B VGM
Price, Consensus and EPS Surprise
WTKWY 150.50 +1.01(0.68%)
Will WTKWY be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for WTKWY based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for WTKWY
Are Consumer Staples Stocks Lagging Marine Harvest ASA (MHGVY) This Year?
Has Sysco (SYY) Outpaced Other Consumer Staples Stocks This Year?
WTKWY: What are Zacks experts saying now?
Zacks Private Portfolio Services
What Makes Wolters Kluwer NV (WTKWY) a Good Fit for 'Trend Investing'
Wolters Kluwer NV (WTKWY) Upgraded to Buy: Here's What You Should Know
Wolters Kluwer NV (WTKWY) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
Other News for WTKWY
Wolters Kluwer introduces Regulatory Audit Module to improve risk adjustment audit validation rates using AI
Wolters Kluwer announces two senior executive appointments
Wolters Kluwer Survey: Over Two-Thirds of U.S. Physicians Have Changed Their Mind, Now Viewing GenAI as Beneficial in Healthcare
Wolters Kluwer Xpitax® Scan Optimizer recognized for excellence in Artificial Intelligence
Wolters Kluwer Experts to Provide Insights on U.S. Corporate Transparency Act Compliance